Exchanges: NASDAQ | NYSE | XLON | AMS | ADS | TSE | BRU
Previous Hold Today FATE ranks #1943 as HOLD CANDIDATE #1943 Next Hold

Fate Therapeutics stock forecast

FATE stock forecast

Wednesday June 19, 2019 Change -1.04% Price $19.99
Chart period: 2019-03-20 - 2019-06-19




Will FATE stock price go up or down on Thu, 20 Jun 2019?


Fate Therapeutics Forecast and Stock Analysis

Technical FATE stock analysis for Wednesday June 19, 2019.

Hold candidate since 2019-06-19

Fate Therapeutics fell by -1.04% in the last day ( Wednesday, 19th Jun 2019 ) from $20.20 to $19.99 During day the stock fluctuated 3.93% from a day low at $19.36 to a day high of $20.12. The price has risen in 6 of the last 10 days and is up by 4.88% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -328 565 shares and in total 636 146 shares bought and sold for approximately $12.72 million.

Quick summary:

  • 30 day high of the FATE stock price was $20.65 and low was $15.55.
  • 90 day high was $20.65 and low was $15.10.
  • 52 week high for the Fate Therapeutics - $20.65 and low - $8.64.


Fate Therapeutics lies in the upper part of a very wide and strong rising trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $20.78 will firstly indicate a stronger raising rate. Given the current short-term trend, the stock is expected to rise 11.26% during the next 3 months and, with 90% probability hold a price between $18.05 and $23.12 at the end of this period.

Click here for today's Top 5 Trending Companies


Fate Therapeutics holds buy signals from both short- and long-term moving averages, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down there will be some support from the lines at $18.18 and $18.22. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Tuesday June 18, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 50 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Fate Therapeutics finds support from accumulated volume at $19.55.

Support: $19.55 Price: $19.99 Resistance: $20.19


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.76 between high and low, or 3.93%. For the last week, the stock has had a daily average volatility of 6.55%.

Our recommended stoploss: $18.95 (-5.21%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from pivot top found 1 days ago.)

6.55 %

Average volatility

Overall risk:

Very Low Low Medium High Very High


Fate Therapeutics holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Hold/Accumulate.

Hold/Accumulate Downgraded
Previous Hold Today FATE ranks #1943 as HOLD CANDIDATE #1943 Next Hold

Will FATE stock price go up or down on Thu, 20 Jun 2019?


Proudly made at

Rise Vilnius
in partnership with
Barclays Bank